Edesa Biotech Inc. (EDSA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Edesa Biotech Inc.

    NASDAQ: EDSA · Real-Time Price · USD
    2.53
    0.00 (0.00%)
    At close: Sep 05, 2025, 3:54 PM
    2.62
    3.56%
    After-hours: Sep 05, 2025, 07:57 PM EDT

    Edesa Biotech Cash Flow Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Net Income
    		 -6.17M -8.37M -17.55M -13.34M
    Depreciation & Amortization
    		 186.05K 183.47K 118.19K 118.79K
    Stock-Based Compensation
    		 537.49K 1.25M 2.26M 3.2M
    Other Working Capital
    		 214.73K 301.5K -2.03B -281.36K
    Other Non-Cash Items
    		 -14.77K 308K 2.38M 3.31M
    Deferred Income Tax
    		 n/a -308K -2.38M -3.31M
    Change in Working Capital
    		 571.07K 308K 2.89M -3.64M
    Operating Cash Flow
    		 -4.89M -6.64M -12.28M -13.66M
    Capital Expenditures
    		 n/a 3.00 -5.66K -6.15K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a -5.66K -6.15K
    Debt Repayment
    		 -29.53K n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a n/a
    Financial Cash Flow
    		 592.03K 4.83M 11.63M 14.17M
    Net Cash Flow
    		 -4.32M -1.73M -748.34K 625.56K
    Free Cash Flow
    		 -4.89M -6.64M -12.28M -13.67M

    Add to Watchlist